Massachusetts Financial Services’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14M Sell
177,598
-56,153
-24% -$4.77M ﹤0.01% 733
2026
Q1
$20.1M Sell
233,751
-27,645
-11% -$2.48M 0.01% 640
2025
Q4
$22.8M Sell
261,396
-420,502
-62% -$31.9M 0.01% 624
2025
Q3
$39.1M Sell
681,898
-165,185
-20% -$9.51M 0.01% 511
2025
Q2
$50M Buy
847,083
+241,313
+40% +$15.6M 0.02% 472
2025
Q1
$44.3M Buy
605,770
+122,417
+25% +$10.1M 0.01% 471
2024
Q4
$40M Buy
483,353
+114,251
+31% +$9.01M 0.01% 494
2024
Q3
$26.4M Buy
+369,102
New +$26.1M 0.01% 561
2014
Q2
Sell
-1,322,737
Closed -$35.2M 900
2014
Q1
$35.2M Sell
1,322,737
-439,540
-25% -$10.4M 0.02% 407
2013
Q4
$35.6M Sell
1,762,277
-10,550
-0.6% -$196K 0.02% 397
2013
Q3
$31M Buy
1,772,827
+1,950
+0.1% +$33.7K 0.02% 404
2013
Q2
$29.9M Buy
+1,770,877
New +$27.3M 0.02% 391

Other funds holding GMED

Massachusetts Financial Services's GMED Position: Q2 2026 in Review

Massachusetts Financial Services reduced its Globus Medical (GMED) stake by 24% in Q2 2026, selling an estimated $4.77M and leaving 177,598 shares worth $14M. The position accounts for ﹤0.01% of the portfolio, ranked #733.

Massachusetts Financial Services first reported a position in GMED in Q2 2013 and has held it in 12 quarters since. The position peaked at $50M in Q2 2025. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Massachusetts Financial Services held 177,598 shares of Globus Medical worth $14M as of Q2 2026.
  • Massachusetts Financial Services sold 56,153 Globus Medical shares in Q2 2026, an estimated $4.77M.
  • Globus Medical made up ﹤0.01% of Massachusetts Financial Services's portfolio in Q2 2026, its #733 holding.
  • Massachusetts Financial Services first reported a position in Globus Medical in Q2 2013 and has held it in 12 quarters since.
  • Massachusetts Financial Services's Globus Medical position peaked at $50M in Q2 2025.
  • 599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Massachusetts Financial Services's 13F filing for Q2 2026, filed 3 Aug 2026.